The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study https://doi.org/10.12982/VIS.2025.076
Article Sidebar
Main Article Content
Abstract
Glypican-3 (GPC-3) and alpha-fetoprotein (AFP) are considered powerful biomarkers for human hepatocellular carcinoma (HCC). The elevation of GPC-3 and AFP gene expression is commonly found in individual HCC patients. The detection of these biomarkers can be achieved with the examination of blood or tissue samples. Moreover, mRNA expressing GPC-3 and AFP are evaluated for detecting HCC in patients. In veterinary practice, data on GPC-3 and AFP of gene expression remain limited. Therefore, this study aims to evaluate the GPC-3 and AFP gene expression in dogs with HCC compared with other hepatic diseases. Twenty dogs were divided into two groups: HCC (n=6), and non-HCC (n=6). The liver tissue and plasma samples of each group were examined for GPC-3 and AFP gene expression by qPCR. The results showed a no statistical difference in the expression levels of GPC-3 gene in liver and plasma samples of dogs with HCC compared with non-HCC dogs. However, there was a positive correlation between the expression of GPC-3 gene and levels of aspartate transaminase (AST) in the HCC group (p-value = 0.002, R = 0.967). Moreover, the sensitivity, specificity, and accuracy of GPC-3 gene expression were higher than AFP gene expression in the HCC group. Therefore, this study conveys the expression of GPC-3 gene and AFP gene, suggesting a potential association with the development of HCC in dogs. The findings, particularly regarding the GPC-3 gene, could contribute to improved diagnostic methods in the future.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publishing an article with open access in Veterinary Integrative Sciences leaves the copyright with the author. The article is published under the Creative Commons Attribution License 4.0 (CC-BY 4.0), which allows users to read, copy, distribute and make derivative works from the material, as long as the author of the original work is cited.
References
Abdelgawad, I.A., Mossallam, G.I., Radwan, N.H., Elzawahry, H.M., Elhifnawy, N.M., 2013. Can glypican3 be diagnostic for early hepatocellular carcinoma among egyptian patients? Asian. Pac. J. Cancer. Prev. 14, 7345-7349.
Balkman, C., 2009. Hepatobiliary neoplasia in dogs and cats. Vet. Clin. North. Am. Small. Anim. Pract. 39, 617-625.
Baumhoer, D., Tornillo, L., Stadlmann, S., Roncalli, M., Diamantis, E.K., Terracciano, L.M., 2008. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am. J. Clin. Pathol. 129, 899-906.
Capurro, M., Wanless, I.R., Sherman, M., Deboer, G., Shi, W., Miyoshi, E., Filmus, J., 2003. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 125, 89-97.
De Las Mulas, J.M., Gómez-Villamandos, J., Pérez, J., Mozos, E., Estrada, M., Méndez, A., 1995. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin. Res. Vet. Sci. 59, 124-127.
Filmus, J., Capurro, M., 2004. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. J. Mol. Diagn. 8, 207-212.
Gibson, E.A., Goldman, R.E., Culp, W.T.N., 2022. Comparative oncology: management of hepatic neoplasia in humans and dogs. Vet. Sci. 9, 489.
Hahn, K.A., Richardson, R.C., 1995. Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia. Vet. Clin. Pathol. 24, 18-21.
Jing, J.S., Ye, W., Jiang, Y.K., Ma, J., Zhu, M.Q., Ma, J.M., Zhou, H., Yu, L.Q., Yang, Y.F., Wang, S.C., 2017. The value of GPC3 and GP73 in clinical diagnosis of hepatocellular carcinoma. Clin. Lab. 11, 1903-1909.
Karaoğullarindan, Ü., Gümürdülü, Y., Üsküdar, O., Odabaş, E., Güler, H.S., Tozluklu, N., Bağir, E., Kuran, S., 2022. Prognostic value and morphological findings of overexpression of glypican-3 in hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 1, 89-93.
Kitao, S., Yamada, T., Ishikawa, T., Madarame, H., Furuichi, M., Neo, S., Tsuchiya, R., Kobayashi, K., 2006. Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma. J. Vet. Diagn. Invest. 18, 291-295.
Kolluri, A., Ho, M., 2019. The role of glypican-3 in regulating Wnt, YAP, and hedgehog in liver cancer. Front. Oncol. 9, 708.
Lapsley, J.M., Wavreille, V., Barry, S., Dornbusch, J.A., Chen, C., Leeper, H., Bertran, J., Scavelli, D., Liptak, J.M., Wood, C., 2022. Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: a veterinary society of surgical oncology case‐control study. Vet. Comp. Oncol. 20, 697-709.
Leela-arporn, R., 2019. The study on diagnosis and clinical aspects of focal liver lesions in dogs. Hokkaido University, Hokkiado, Japan.
Leela-Arporn, R., Ohta, H., Tamura, M., Nagata, N., Sasaoka, K., Dermlim, A., Nisa, K., Morishita, K., Sasaki, N., Nakamura, K., 2019. Predictive factors of malignancy in dogs with focal liver lesions using clinical data and ultrasonographic features. J. Vet. Med. Sci. 81, 723-729.
Leela-Arporn, R., Ohta, H., Nagata, N., Sasaoka, K., Tamura, M., Dermlim, A., Nisa, K., Morishita, K., Sasaki, N., Nakamura, K., Takagi, S., Hosoya, K., Takiguchi, M., 2019. Epidemiology of massive hepatocellular carcinoma in dogs: a 4-year retrospective study. Vet. J. 248, 74-78.
Li, B., Liu, H., Shang, H., Li, P., Li, N., Ding, H., 2013. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients. Afr. Health. Sci. 13, 703-709.
Li, B.D., Zhao, Q.C., Zhu, Y.T., Zhang, F.Q., Dou, K.F., 2006. Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells. Zhonghua. Wai. Ke. Za. Zhi. 44, 458-462.
Liptak, J., Dernell, W., Withrow, S.J., 2004. Liver tumors in cats and dogs. Compend. Contin. Educ. Vet. 26, 50-56.
Liptak, J.M., Dernell, W.S., Monnet, E., Powers, B.E., Bachand, A.M., Kenney, J.G., Withrow, S.J., 2004. Massive hepatocellular carcinoma in dogs: 48 cases (1992–2002). J. Am. Vet. Med. Assoc. 225, 1225-1230.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 25, 402-408.
Masserdotti, C., Drigo, M., 2012. Retrospective study of cytologic features of well‐differentiated hepatocellular carcinoma in dogs. Vet. Clin. Pathol. 41, 382-390.
McGlynn, K.A., London, W.T., 2011. The global epidemiology of hepatocellular carcinoma: present and future. Clin. Liver. Dis. 15, 223-243.
Moyer, J., Lopez, D.J., Balkman, C.E., Sumner, J.P., 2021. Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007–2018). Open. Vet. J. 11, 144-153.
Nagtegaal, I.D., Odze, R.D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K.M., Carneiro, F., Cree, I.A., 2020. The 2019 WHO classification of tumours of the digestive system. Histopathology. 76, 182.
Nakatsura, T., Kageshita, T., Ito, S., Wakamatsu, K., Monji, M., Ikuta, Y., Senju, S., Ono, T., Nishimura, Y., 2004. Identification of glypican-3 as a novel tumor marker for melanoma. Clin. Cancer. Res. 10, 6612-6621.
Nakatsura, T., Yoshitake, Y., Senju, S., Monji, M., Komori, H., Motomura, Y., Hosaka, S., Beppu, T., Ishiko, T., Kamohara, H., Ashihara, H., Katagiri, T., Furukawa, Y., Fujiyama, S., Ogawa, M., Nakamura, Y., Nishimura, Y., 2003. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem. Biophys. Res. Commun. 306, 16-25.
Pan, Z., Chen, C., Long, H., Lei, C., Tang, G., Li, L., Feng, J., Chen, F., 2013. Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis. Mol. Med. Rep. 7, 969-974.
Patnaik, A., Hurvitz, A., Lieberman, P., Johnson, G., 1981. Canine hepatocellular carcinoma. Vet. Pathol. 18, 427-438.
Shirakawa, H., Kuronuma, T., Nishimura, Y., Hasebe, T., Nakano, M., Gotohda, N., Takahashi, S., Nakagohri, T., Konishi, M., Kobayashi, N., 2009. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int. J. Oncol. 34, 649-656.
Tahon, A.M., El-Ghanam, M.Z., Zaky, S., Emran, T.M., Bersy, A.M., El-Raey, F., AZ, E., El Kharsawy, A.M., Johar, D., 2019. Significance of glypican-3 in early detection of hepatocellular carcinoma in cirrhotic patients. J. Gastrointest. Cancer. 50, 434-441.
Teshima, T., Matsumoto, H., Shigihara, K., Sawada, H., Michishita, M., Takahashi, K., Koyama, H., 2013. Hepatocellular carcinoma in a young dog. Can. Vet. J. 54, 845.
Toh, M.R., Wong, E.Y.T., Wong, S.H., Ng, A.W.T., Loo, L.H., Chow, P.K.H., Ngeow, J., 2023. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology. 164, 766-782.
van Sprundel, R.G., van den Ingh, T.S., Desmet, V.J., Katoonizadeh, A., Penning, L.C., Rothuizen, J., Roskams, T., Spee, B., 2010. Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp. hepatol. 9, 1-11.
Wang, L., Yao, M., Dong, Z., Zhang, Y., Yao, D., 2014. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour. Biol. 35, 9-20.
Wang, S., Chen, N., Chen, Y., Sun, L., Li, L., Liu, H., 2018. Elevated GPC3 level promotes cell proliferation in liver cancer. Oncol. Lett. 16, 970-976.
Wang, Y.L., Li, G., Wu, D., Liu, Y.W., Yao, Z., 2007. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation. Transplant. Proc. 39, 166-168.
Wu, Y., Liu, H., Ding, H., 2016. GPC-3 in hepatocellular carcinoma: current perspectives. J. Hepatocell. Carcinoma. 3, 63-67.
Yamada, T., Fujita, M., Kitao, S., Ashida, Y., Nishizono, K., Tsuchiya, R., Shida, T., Kobayashi, K., 1999. Serum alpha-fetoprotein values in dogs with various hepatic diseases. J. Vet. Med. Sci. 61, 657-659.
Yao, M., Yao, D.F., Bian, Y.Z., Wu, W., Yan, X.D., Yu, D.D., Qiu, L.W., Yang, J.L., Zhang, H.J., Sai, W.L., 2013. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Hepatobiliary. Pancreat. Dis. Int. 12, 171-179.